Literature DB >> 21521385

Post-traumatic stress disorder, depression and suicidality in inpatients with substance use disorders.

Glenys Dore1, Katherine Mills, Robin Murray, Maree Teesson, Philippa Farrugia.   

Abstract

INTRODUCTION AND AIMS: The international literature suggests that traumatic events are common for patients with substance use disorders (SUDs), and are often associated with the development of post-traumatic stress disorder (PTSD) and other psychiatric comorbidities. However, limited research has been conducted among Australian SUD patients. The aim of the present study was to examine the prevalence of these disorders in a group of Australian patients admitted for detoxification. DESIGN AND METHODS: Data were collected from 253 inpatients using a modified version of the Composite International Diagnostic Interview, the 10-item Trauma Screening Questionnaire, the Zung Self-rating Depression Scale and questions from the PsyCheck.
RESULTS: Approximately 20% of inpatients experienced moderate to severe depressive symptoms, and 37% had a lifetime history of self-harm or attempted suicide. Approximately 80% of patients had experienced at least one traumatic event, most experiencing multiple traumas. The mean age of first trauma was 14years. Almost 45% of patients screened positive for current PTSD symptoms. Women were nine times more likely to have been raped and five times more likely to have been sexually molested than men. PTSD symptoms were associated with greater trauma exposure, younger age of first trauma, specific trauma types, moderate to severe depressive symptoms and a history of self-harm or attempted suicide. Despite their difficulties, patients with PTSD symptoms had high rates of retention in treatment. DISCUSSION AND
CONCLUSIONS: Patients entering treatment for SUDs should be assessed for PTSD, depression and suicidality. These conditions impact significantly on treatment outcomes, and require the development of appropriate treatment strategies.
© 2011 Australasian Professional Society on Alcohol and other Drugs.

Entities:  

Mesh:

Year:  2011        PMID: 21521385     DOI: 10.1111/j.1465-3362.2011.00314.x

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  19 in total

1.  Risk and protective factors associated with substance use disorders in adolescents with first-episode mania.

Authors:  Jacob R Stephens; Jaimee L Heffner; Caleb M Adler; Thomas J Blom; Robert M Anthenelli; David E Fleck; Jeffrey A Welge; Stephen M Strakowski; Melissa P DelBello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-05-10       Impact factor: 8.829

2.  The intervening role of urgency on the association between childhood maltreatment, PTSD, and substance-related problems.

Authors:  Rebecca Mirhashem; Holley C Allen; Zachary W Adams; Katherine van Stolk-Cooke; Alison Legrand; Matthew Price
Journal:  Addict Behav       Date:  2017-02-10       Impact factor: 3.913

3.  Prevalence and Predictors of Symptoms of Depression Among Individuals Seeking Treatment from Australian Drug and Alcohol Outpatient Clinics.

Authors:  Breanne Hobden; Mariko Carey; Jamie Bryant; Rob Sanson-Fisher; Christopher Oldmeadow
Journal:  Community Ment Health J       Date:  2019-09-12

4.  Randomized controlled trial of enhanced telephone monitoring with detoxification patients: 3- and 6-month outcomes.

Authors:  Christine Timko; Maureen Below; Lisa Vittorio; Emmeline Taylor; Grace Chang; Steven Lash; Fe Erlita D Festin; Deborah Brief
Journal:  J Subst Abuse Treat       Date:  2019-01-04

5.  Do race/ethnicity and religious affiliation moderate treatment outcomes among individuals with co-occurring PTSD and substance use disorders?

Authors:  Lesia M Ruglass; Ann M Yali
Journal:  J Prev Interv Community       Date:  2019-05-11

6.  Concurrent treatment of PTSD and alcohol use disorder via telehealth in a female Iraq veteran.

Authors:  Maryanne Jaconis; Elizabeth J Santa Ana; Therese K Killeen; Christal L Badour; Sudie E Back
Journal:  Am J Addict       Date:  2017-01-24

7.  De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease.

Authors:  Loren G Rabinowitz; Haley M Zylberberg; Jeong Yang; Stephanie Lauren Gold; Jaclyn Chesner; Jiayi Ji; Liangyuan Hu; Marla Dubinsky
Journal:  Dig Dis Sci       Date:  2021-10-06       Impact factor: 3.487

8.  Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity.

Authors:  Andrea Meier; Chantal Lambert-Harris; Mark P McGovern; Haiyi Xie; Melissa An; Bethany McLeman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-05-08       Impact factor: 3.829

9.  Does Posttraumatic Stress Disorder (PTSD) Affect Post-Treatment Methamphetamine Use?

Authors:  Suzette Glasner-Edwards; Larissa J Mooney; Alfonso Ang; Maureen Hillhouse; Richard Rawson
Journal:  J Dual Diagn       Date:  2013-04-01

10.  Design of CLARO (Collaboration Leading to Addiction Treatment and Recovery from other Stresses): A randomized trial of collaborative care for opioid use disorder and co-occurring depression and/or posttraumatic stress disorder.

Authors:  Lisa S Meredith; Miriam S Komaromy; Matthew Cefalu; Cristina Murray-Krezan; Kimberly Page; Karen Chan Osilla; Alex R Dopp; Isabel Leamon; Lina Tarhuni; Grace Hindmarch; Vanessa Jacobsohn; Katherine E Watkins
Journal:  Contemp Clin Trials       Date:  2021-03-10       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.